Bioadhesive microspheres as a potential nasal drug delivery system

Abstract The rapid mucociliary clearance mechanism in the nasal cavity can be considered as an important factor when low bioavailabilities are obtained for drugs given intranasally. A nasal delivery system in the form of bioadhesive microspheres has been developed. Studies in human volunteers using gamma scintigraphy showed great differences in clearance times between 3 microsphere systems and two controls. The half life of clearance for starch microspheres was found to be in the order of 240 min as compared to 15 min for the liquid and powder control formulations. The microspheres form a gel-like layer in contact with the nasal mucosa that is cleared slowly from the nasal cavity. In vitro studies using model compounds (cromoglycate and Rose bengal) showed high degrees of loading capacities for the various microsphere systems. Using various physical and chemical approaches, it was possible to a certain degree to control the release of the compounds from the microsphere systems.

[1]  Kinam Park,et al.  Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion , 1984 .

[2]  J. Flier,et al.  Insulin Administered Intranasally as an Insulin-Bile Salt Aerosol: Effectiveness and Reproducibility in Normal and Diabetic Subjects , 1983, Diabetes.

[3]  Donald F. Proctor,et al.  The Nose, upper airway physiology and the atmospheric environment , 1982 .

[4]  L G Mendelsohn,et al.  Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats. , 1985, Journal of pharmaceutical sciences.

[5]  V. H. Lee.  Enzymatic Barriers to Peptide and Protein Absorption and the Use of Penetration Enhancers to Modify Absorption , 1986 .

[6]  S. Hirai,et al.  Nasal absorption of natural contraceptive steroids in rats-progesterone absorption. , 1981, Journal of pharmaceutical sciences.

[7]  J. Manson,et al.  Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. , 1985 .

[8]  M. Vance,et al.  Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men. , 1983, The Journal of clinical endocrinology and metabolism.

[9]  Y. Takatsuka,et al.  Mechanisms for the enhancement of the nasal absorption of insulin by surfactants , 1981 .

[10]  R. McClellan,et al.  Nasal absorption of DTPA in rats. , 1980, Health physics.

[11]  K Morimoto,et al.  Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel , 1985, The Journal of pharmacy and pharmacology.

[12]  T. Kashihara,et al.  Nasal absorption of propranolol in humans. , 1979, Journal of pharmaceutical sciences.

[13]  Nikolaos A. Peppas,et al.  Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues , 1985 .

[14]  I. Sjöholm,et al.  Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. , 1979, Molecular pharmacology.

[15]  C. Bergquist,et al.  INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENT , 1979, The Lancet.

[16]  Nagai Tsuneji,et al.  Powder dosage form of insulin for nasal administration , 1984 .

[17]  F. Aoki,et al.  Distribution and removal of human serum albumin-technetium 99m instilled intranasally. , 1976, British journal of clinical pharmacology.

[18]  M. Augustine,et al.  Intranasal Delivery of the Peptide, Salmon Calcitonin , 1986 .

[19]  J. Hardy,et al.  Intranasal drug delivery by spray and drops , 1985, The Journal of pharmacy and pharmacology.

[20]  S. Hirai,et al.  Nasal absorption of propranolol from different dosage forms by rats and dogs. , 1980, Journal of pharmaceutical sciences.